Sphingomyelin Is A Candidate Predictor For Lung Adenocarcinoma Recurrence After Radical Surgery

For efficient application of adjuvant chemotherapy after radical surgery for lung cancer, identifying recurrence high risk group is needed. However, predicting lung cancer recurrence after radical surgery is difficult even with numbers of histopathological prognostic factors reported ever. Because subjective judgements for the conventional histopathological prognostic factors are inevitable, novel prognostic factor with high objectivity is expected. Lipid metabolism alterations are known to contribute to cancer progression.